Skip to main content
Clinical Trials/NCT01014377
NCT01014377
Completed
Not Applicable

Assessment of the Safety of the VascuActive™ Device and Its Preliminary Efficacy on Foot Perfusion, Hemodynamics and Exercise Capacity in Patients With Peripheral Vascular Disease and Limb Ischemia

VascuActive LTD1 site in 1 country15 target enrollmentNovember 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Vascular Diseases
Sponsor
VascuActive LTD
Enrollment
15
Locations
1
Primary Endpoint
Pain-free and Maximal walking distance
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to assess the safety and the immediate effect of the VascuActive device on patients with peripheral vascular disease and limb ischemia.

Registry
clinicaltrials.gov
Start Date
November 2009
End Date
April 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
VascuActive LTD

Eligibility Criteria

Inclusion Criteria

  • Leg Ischemia, Fontaine grade IIa and IIb, i.e.: pain free walking distance in the range of 50 - 100 meters.
  • Absent pulses in the two foot arteries (Anterior Tibial a., Posterior Tibial a.)
  • ABI \< 0.7 by Doppler, in at least one of the two foot arteries

Exclusion Criteria

  • Absent femoral pulses
  • Venous insufficiency by Duplex
  • Pregnancy
  • Infectious disease
  • Malignant disease
  • Severe cardiac disease, e.g., CHF grade 3 or higher
  • Acute MI within last 3 months
  • CABG within last 3 months
  • Other severe systemic disease

Outcomes

Primary Outcomes

Pain-free and Maximal walking distance

Time Frame: 1 hour

Secondary Outcomes

  • Skin temperature(1 hour)
  • Skin blood flow(1 hour)
  • Transcutaneous partial pressure of O2 and CO2(1 hour)

Study Sites (1)

Loading locations...

Similar Trials